| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
40,489 |
37,265 |
$11.64M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
30,754 |
27,767 |
$10.24M |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
25,197 |
20,101 |
$7.81M |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
13,825 |
12,299 |
$3.97M |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
4,975 |
4,485 |
$3.41M |
| G0378 |
Hospital observation service, per hour |
6,412 |
5,162 |
$2.60M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
5,799 |
5,318 |
$2.55M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
5,912 |
5,332 |
$2.17M |
| A0434 |
Specialty care transport (sct) |
3,762 |
3,115 |
$1.61M |
| 93017 |
|
6,493 |
5,704 |
$1.54M |
| 93458 |
|
1,256 |
1,059 |
$1.49M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
10,693 |
10,045 |
$1.43M |
| A0425 |
Ground mileage, per statute mile |
52,331 |
39,429 |
$1.12M |
| 29581 |
|
2,688 |
829 |
$1.02M |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
1,415 |
1,330 |
$933K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
4,971 |
4,558 |
$813K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
1,917 |
1,796 |
$734K |
| OP370 |
|
5,090 |
4,298 |
$698K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
2,716 |
1,707 |
$604K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
8,642 |
8,168 |
$582K |
| OP710 |
|
3,871 |
3,318 |
$442K |
| 93880 |
|
1,756 |
1,573 |
$439K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
17,549 |
15,829 |
$436K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
14,748 |
12,786 |
$386K |
| 70450 |
Computed tomography, head or brain; without contrast material |
7,086 |
6,302 |
$373K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
456 |
402 |
$364K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
25,515 |
21,023 |
$351K |
| 71046 |
Radiologic examination, chest; 2 views |
13,516 |
12,582 |
$348K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
382 |
344 |
$338K |
| 90834 |
Psychotherapy, 45 minutes with patient |
5,828 |
2,658 |
$336K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
3,408 |
3,279 |
$327K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
3,992 |
2,615 |
$291K |
| A0428 |
Ambulance service, basic life support, non-emergency transport, (bls) |
9,447 |
5,432 |
$286K |
| A0433 |
Advanced life support, level 2 (als 2) |
767 |
712 |
$280K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
9,882 |
8,810 |
$278K |
| OP272 |
|
9,366 |
7,738 |
$278K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
2,252 |
1,928 |
$270K |
| 80053 |
Comprehensive metabolic panel |
43,253 |
34,240 |
$235K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
169 |
145 |
$226K |
| 64483 |
|
310 |
287 |
$225K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
8,886 |
7,588 |
$221K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,846 |
1,696 |
$217K |
| 93970 |
|
1,166 |
1,059 |
$217K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
622 |
575 |
$201K |
| C9600 |
Percutaneous transcatheter placement of drug eluting intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch |
129 |
94 |
$197K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
394 |
350 |
$191K |
| 95708 |
|
295 |
262 |
$191K |
| 76830 |
Ultrasound, transvaginal |
1,899 |
1,801 |
$186K |
| 29580 |
|
3,397 |
998 |
$182K |
| 76641 |
|
1,054 |
870 |
$165K |
| 70496 |
|
1,480 |
1,302 |
$160K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,639 |
1,479 |
$158K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
10,287 |
8,667 |
$154K |
| 72141 |
|
436 |
398 |
$150K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
3,563 |
3,247 |
$141K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
3,432 |
2,918 |
$140K |
| 76801 |
|
1,478 |
1,273 |
$135K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,685 |
1,575 |
$126K |
| 70498 |
|
1,344 |
1,205 |
$126K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
42,428 |
32,959 |
$125K |
| 71045 |
Radiologic examination, chest; single view |
8,928 |
7,811 |
$121K |
| 77066 |
Tomosynthesis, mammo |
874 |
814 |
$114K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
103 |
88 |
$114K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
969 |
927 |
$109K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
546 |
505 |
$105K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,041 |
960 |
$103K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
3,389 |
3,262 |
$101K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
133 |
124 |
$101K |
| 95700 |
|
377 |
353 |
$99K |
| 93971 |
|
832 |
760 |
$94K |
| 76642 |
|
797 |
742 |
$94K |
| J2785 |
Injection, regadenoson, 0.1 mg |
2,574 |
2,219 |
$92K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
808 |
741 |
$92K |
| 71250 |
|
813 |
747 |
$92K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
1,526 |
1,203 |
$91K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
2,270 |
2,104 |
$89K |
| OP250 |
|
77,687 |
51,059 |
$86K |
| 77080 |
|
793 |
733 |
$82K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,155 |
2,016 |
$82K |
| 70544 |
|
324 |
289 |
$77K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
343 |
214 |
$73K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
5,021 |
4,347 |
$73K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
9,843 |
7,938 |
$72K |
| 72110 |
|
1,323 |
1,229 |
$71K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,882 |
1,655 |
$69K |
| 77065 |
Tomosynthesis, mammo |
986 |
876 |
$68K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,161 |
1,058 |
$66K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
431 |
387 |
$63K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
993 |
758 |
$55K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
8,213 |
7,629 |
$55K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,318 |
1,148 |
$55K |
| 73030 |
|
1,659 |
1,492 |
$54K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
5,156 |
4,581 |
$50K |
| 76536 |
|
393 |
368 |
$49K |
| 84443 |
Thyroid stimulating hormone (TSH) |
6,936 |
6,203 |
$49K |
| 90791 |
Psychiatric diagnostic evaluation |
1,399 |
1,214 |
$47K |
| 75574 |
|
140 |
130 |
$45K |
| 76770 |
|
608 |
558 |
$44K |
| C1760 |
Closure device, vascular (implantable/insertable) |
694 |
582 |
$43K |
| 84484 |
|
16,772 |
13,385 |
$42K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
381 |
300 |
$41K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
1,392 |
1,292 |
$40K |
| 85730 |
|
13,086 |
11,259 |
$39K |
| 80061 |
Lipid panel |
5,460 |
5,065 |
$38K |
| 93925 |
|
151 |
138 |
$38K |
| 73564 |
|
1,413 |
1,258 |
$38K |
| 85027 |
|
11,218 |
9,105 |
$37K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
5,920 |
4,879 |
$37K |
| 85610 |
|
14,306 |
11,967 |
$36K |
| 36415 |
Collection of venous blood by venipuncture |
51,594 |
39,521 |
$36K |
| C1874 |
Stent, coated/covered, with delivery system |
206 |
149 |
$35K |
| 86900 |
|
5,411 |
4,376 |
$34K |
| 73630 |
|
1,794 |
1,635 |
$34K |
| 76706 |
|
651 |
555 |
$34K |
| 81455 |
|
295 |
254 |
$33K |
| 96367 |
|
685 |
442 |
$33K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
55 |
45 |
$32K |
| 97602 |
|
628 |
217 |
$32K |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
5,593 |
4,688 |
$32K |
| OP258 |
|
30,663 |
22,545 |
$31K |
| 73130 |
|
1,438 |
1,311 |
$31K |
| 76937 |
|
1,526 |
1,250 |
$31K |
| C1769 |
Guide wire |
1,639 |
1,133 |
$30K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,977 |
1,777 |
$29K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,873 |
1,751 |
$29K |
| 70486 |
|
594 |
537 |
$29K |
| OP270 |
|
4,977 |
4,325 |
$26K |
| 83880 |
|
5,325 |
4,487 |
$26K |
| 74019 |
|
1,948 |
1,806 |
$23K |
| 96376 |
|
1,753 |
1,492 |
$23K |
| 90832 |
Psychotherapy, 30 minutes with patient |
375 |
254 |
$21K |
| 86850 |
|
5,597 |
4,494 |
$21K |
| 73610 |
|
1,773 |
1,645 |
$21K |
| 81025 |
|
16,096 |
14,373 |
$21K |
| 47562 |
|
12 |
12 |
$21K |
| 74018 |
|
1,817 |
1,676 |
$19K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
2,846 |
2,683 |
$19K |
| 87070 |
|
9,520 |
8,791 |
$19K |
| 92083 |
|
330 |
310 |
$18K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
5,671 |
5,239 |
$18K |
| 83735 |
|
8,837 |
6,980 |
$18K |
| 73562 |
|
538 |
482 |
$17K |
| 72052 |
|
454 |
410 |
$17K |
| 81001 |
|
16,608 |
14,791 |
$17K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
643 |
152 |
$16K |
| 82962 |
|
10,572 |
7,088 |
$16K |
| 76820 |
|
197 |
100 |
$16K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,874 |
1,752 |
$16K |
| 73502 |
|
906 |
812 |
$16K |
| J1245 |
Injection, dipyridamole, per 10 mg |
1,881 |
1,613 |
$16K |
| 70491 |
|
97 |
90 |
$15K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,350 |
1,216 |
$15K |
| 83605 |
|
5,855 |
5,040 |
$15K |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
334 |
254 |
$15K |
| 86901 |
|
5,466 |
4,382 |
$15K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
114 |
98 |
$14K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
5,497 |
4,906 |
$14K |
| J0280 |
Injection, aminophyllin, up to 250 mg |
2,426 |
2,100 |
$14K |
| 72131 |
|
233 |
215 |
$14K |
| 87040 |
|
1,554 |
1,327 |
$13K |
| 19083 |
|
13 |
13 |
$12K |
| 36430 |
|
282 |
205 |
$12K |
| 76813 |
|
99 |
92 |
$12K |
| A4648 |
Tissue marker, implantable, any type, each |
359 |
316 |
$12K |
| 83690 |
|
9,119 |
8,039 |
$12K |
| 73110 |
|
810 |
749 |
$12K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
9,765 |
9,032 |
$11K |
| 95811 |
|
12 |
12 |
$11K |
| 93922 |
|
65 |
64 |
$11K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,969 |
534 |
$10K |
| 97162 |
|
499 |
433 |
$10K |
| 82607 |
|
1,653 |
1,469 |
$10K |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
198 |
174 |
$10K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
224 |
170 |
$10K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
570 |
526 |
$10K |
| 84145 |
|
2,605 |
2,248 |
$10K |
| 88341 |
|
78 |
65 |
$10K |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
1,515 |
1,206 |
$9K |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
2,304 |
2,137 |
$9K |
| 84702 |
|
2,976 |
2,382 |
$9K |
| 73080 |
|
535 |
489 |
$9K |
| 90715 |
|
1,200 |
1,106 |
$9K |
| 88304 |
|
535 |
481 |
$9K |
| 86803 |
|
717 |
667 |
$9K |
| 59025 |
Fetal non-stress test |
111 |
97 |
$9K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
367 |
347 |
$9K |
| J3490 |
Unclassified drugs |
4,664 |
3,694 |
$9K |
| 92133 |
|
323 |
311 |
$9K |
| 82077 |
|
2,820 |
2,408 |
$8K |
| 97161 |
|
415 |
389 |
$8K |
| 94375 |
|
98 |
93 |
$8K |
| 81003 |
|
8,030 |
7,286 |
$8K |
| 12001 |
|
477 |
442 |
$8K |
| 95816 |
|
59 |
55 |
$7K |
| 73590 |
|
646 |
594 |
$7K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,118 |
462 |
$7K |
| 93976 |
|
91 |
85 |
$7K |
| 87186 |
|
2,068 |
1,825 |
$7K |
| 84153 |
|
405 |
385 |
$7K |
| 84439 |
|
1,524 |
1,356 |
$7K |
| 86140 |
|
5,861 |
5,252 |
$7K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
1,262 |
1,013 |
$6K |
| 12011 |
|
400 |
358 |
$6K |
| 72100 |
|
408 |
373 |
$6K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
5,770 |
4,795 |
$6K |
| 87340 |
|
781 |
708 |
$6K |
| 88312 |
|
380 |
339 |
$6K |
| J2916 |
Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg |
219 |
93 |
$6K |
| C1889 |
Implantable/insertable device, not otherwise classified |
18 |
15 |
$6K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,095 |
754 |
$6K |
| 73090 |
|
490 |
452 |
$6K |
| 94760 |
|
382 |
267 |
$6K |
| 87480 |
|
297 |
280 |
$6K |
| 70547 |
|
27 |
25 |
$6K |
| 87660 |
|
297 |
280 |
$6K |
| 72197 |
|
12 |
12 |
$6K |
| 80047 |
|
4,153 |
3,765 |
$6K |
| 82728 |
|
961 |
837 |
$5K |
| 73560 |
|
196 |
165 |
$5K |
| J2704 |
Injection, propofol, 10 mg |
4,812 |
4,170 |
$5K |
| 80143 |
|
1,891 |
1,645 |
$5K |
| 80179 |
|
1,865 |
1,621 |
$5K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,393 |
1,149 |
$5K |
| 71271 |
|
26 |
24 |
$5K |
| 86703 |
|
594 |
514 |
$5K |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
1,742 |
1,302 |
$5K |
| 73140 |
|
520 |
490 |
$5K |
| 95886 |
|
58 |
53 |
$5K |
| 84100 |
|
3,326 |
2,604 |
$4K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
170 |
166 |
$4K |
| 29515 |
|
160 |
143 |
$4K |
| 76870 |
|
110 |
99 |
$4K |
| 84480 |
|
800 |
716 |
$4K |
| 88360 |
|
97 |
83 |
$4K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
16 |
15 |
$4K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
13,687 |
11,482 |
$4K |
| 82746 |
|
737 |
643 |
$4K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
267 |
227 |
$3K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
12 |
12 |
$3K |
| C1753 |
Catheter, intravascular ultrasound |
15 |
13 |
$3K |
| 88342 |
|
105 |
89 |
$3K |
| G0379 |
Direct admission of patient for hospital observation care |
14 |
12 |
$3K |
| 94729 |
|
82 |
78 |
$3K |
| 87807 |
|
2,822 |
2,652 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
5,769 |
4,816 |
$3K |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
1,026 |
519 |
$3K |
| 97803 |
|
31 |
27 |
$3K |
| 15853 |
|
77 |
66 |
$3K |
| 83550 |
|
941 |
808 |
$3K |
| 94200 |
|
84 |
79 |
$3K |
| 96415 |
|
18 |
12 |
$3K |
| 85379 |
|
2,272 |
2,074 |
$3K |
| 95800 |
|
14 |
13 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
89 |
77 |
$3K |
| 87510 |
|
339 |
280 |
$3K |
| 86593 |
|
1,015 |
929 |
$3K |
| J1644 |
Injection, heparin sodium, per 1000 units |
2,834 |
1,676 |
$3K |
| 97605 |
|
60 |
12 |
$3K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
9,550 |
7,836 |
$2K |
| 29125 |
|
300 |
276 |
$2K |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
957 |
825 |
$2K |
| 80177 |
|
591 |
466 |
$2K |
| 64615 |
|
45 |
44 |
$2K |
| 83540 |
|
1,038 |
894 |
$2K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
4,294 |
3,695 |
$2K |
| 72072 |
|
44 |
42 |
$2K |
| 82550 |
|
1,465 |
1,258 |
$2K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
786 |
707 |
$2K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,206 |
1,026 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
3,349 |
2,503 |
$2K |
| 80076 |
|
965 |
871 |
$2K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,781 |
1,292 |
$2K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
1,141 |
913 |
$2K |
| 87088 |
|
1,716 |
1,532 |
$2K |
| 82248 |
|
365 |
286 |
$2K |
| 81002 |
|
4,948 |
4,546 |
$2K |
| 77280 |
|
13 |
12 |
$2K |
| 73523 |
|
28 |
25 |
$2K |
| 92611 |
|
13 |
13 |
$2K |
| 94727 |
|
41 |
41 |
$2K |
| 95819 |
|
12 |
12 |
$2K |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
1,272 |
1,104 |
$2K |
| 88307 |
|
12 |
12 |
$1K |
| 74230 |
|
26 |
25 |
$1K |
| 85014 |
|
4,418 |
3,941 |
$1K |
| 71101 |
|
126 |
103 |
$1K |
| 10060 |
|
45 |
40 |
$1K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
2,123 |
1,542 |
$1K |
| 0004A |
|
47 |
46 |
$1K |
| 85652 |
|
1,571 |
1,357 |
$1K |
| 82803 |
|
317 |
263 |
$1K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
203 |
55 |
$1K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
3,212 |
2,815 |
$1K |
| 84550 |
|
684 |
566 |
$1K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
3,132 |
2,485 |
$1K |
| 73552 |
|
77 |
69 |
$1K |
| 84436 |
|
572 |
515 |
$1K |
| 82043 |
|
549 |
511 |
$1K |
| 87077 |
|
707 |
654 |
$995.54 |
| 80074 |
|
108 |
85 |
$966.32 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
555 |
492 |
$948.10 |
| J3480 |
Injection, potassium chloride, per 2 meq |
891 |
609 |
$931.51 |
| 64484 |
|
13 |
12 |
$930.27 |
| 73060 |
|
82 |
74 |
$897.92 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
1,188 |
591 |
$895.61 |
| Q9965 |
Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml |
794 |
717 |
$886.86 |
| 72040 |
|
64 |
56 |
$837.31 |
| 87075 |
|
246 |
212 |
$823.50 |
| 82247 |
|
150 |
100 |
$776.00 |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
93 |
37 |
$702.37 |
| 82570 |
|
420 |
348 |
$668.02 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
836 |
727 |
$655.86 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
1,310 |
1,154 |
$618.14 |
| 74022 |
|
48 |
47 |
$555.16 |
| 77002 |
|
16 |
14 |
$544.52 |
| 29505 |
|
30 |
27 |
$540.62 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
88 |
60 |
$525.91 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
479 |
385 |
$512.97 |
| J2305 |
Injection, nitroglycerin, 5 mg |
499 |
423 |
$491.68 |
| J7510 |
Prednisolone oral, per 5 mg |
1,322 |
1,168 |
$478.23 |
| 87205 |
|
483 |
380 |
$474.59 |
| C9113 |
Injection, pantoprazole sodium, per vial |
778 |
422 |
$468.12 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
373 |
268 |
$445.78 |
| 86308 |
|
572 |
533 |
$432.09 |
| J2060 |
Injection, lorazepam, 2 mg |
872 |
677 |
$426.92 |
| OP637 |
|
2,646 |
1,498 |
$346.92 |
| 95874 |
|
169 |
163 |
$322.19 |
| 86762 |
|
42 |
37 |
$321.04 |
| L1830 |
Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf |
137 |
117 |
$315.48 |
| 12002 |
|
59 |
54 |
$289.15 |
| 86618 |
|
34 |
27 |
$284.58 |
| J1630 |
Injection, haloperidol, up to 5 mg |
536 |
415 |
$276.51 |
| J7042 |
5% dextrose/normal saline (500 ml = 1 unit) |
315 |
228 |
$273.46 |
| 82784 |
|
18 |
12 |
$270.07 |
| 80164 |
|
91 |
71 |
$267.99 |
| 29130 |
|
62 |
58 |
$260.30 |
| 86038 |
|
65 |
56 |
$240.34 |
| 87081 |
|
60 |
56 |
$233.96 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
330 |
248 |
$223.06 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
1,492 |
1,266 |
$203.47 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
803 |
485 |
$193.71 |
| J1953 |
Injection, levetiracetam, 10 mg |
143 |
99 |
$192.99 |
| 82010 |
|
61 |
56 |
$173.61 |
| 86706 |
|
24 |
24 |
$151.41 |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
12 |
12 |
$141.56 |
| J1643 |
Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units |
276 |
201 |
$125.23 |
| 86923 |
|
13 |
12 |
$110.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
30 |
26 |
$104.61 |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
36 |
14 |
$103.92 |
| 84134 |
|
34 |
24 |
$96.73 |
| 97165 |
|
14 |
14 |
$94.73 |
| 85018 |
|
103 |
88 |
$88.00 |
| 84481 |
|
15 |
12 |
$82.50 |
| 83615 |
|
36 |
27 |
$82.11 |
| 73100 |
|
14 |
12 |
$70.36 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
139 |
92 |
$66.32 |
| 85045 |
|
15 |
13 |
$59.34 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
95 |
63 |
$58.99 |
| L4350 |
Ankle control orthosis, stirrup style, rigid, includes any type interface (e.g., pneumatic, gel), prefabricated, off-the-shelf |
51 |
50 |
$56.48 |
| 88311 |
|
14 |
14 |
$52.34 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
104 |
99 |
$51.47 |
| 84132 |
|
35 |
25 |
$48.77 |
| 64644 |
|
18 |
18 |
$43.27 |
| 82805 |
|
13 |
12 |
$30.45 |
| 64643 |
|
26 |
26 |
$26.77 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
68 |
66 |
$25.46 |
| J1940 |
Injection, furosemide, up to 20 mg |
82 |
49 |
$25.23 |
| 82150 |
|
27 |
25 |
$23.81 |
| J1920 |
Injection, labetalol hydrochloride, 5 mg |
75 |
58 |
$22.76 |
| J0687 |
Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mg |
371 |
276 |
$20.08 |
| 84156 |
|
20 |
12 |
$19.66 |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
31 |
28 |
$19.37 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
66 |
49 |
$18.67 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
550 |
405 |
$12.22 |
| 91300 |
|
57 |
53 |
$0.00 |
| 91307 |
|
13 |
12 |
$0.00 |